Prevalence of cardiovascular disease (CVD) risk factors and receipt of preventive care among prostate cancer (CaP) survivors in the United States.

Authors

null

Kevin Alexander Pearlstein

The University of North Caroline-Chapel Hill, School of Medicine, Chapel Hill, NC

Kevin Alexander Pearlstein , Laura H. Hendrix , Trevor Joseph Royce , William A. Stokes , Ronald C. Chen

Organizations

The University of North Caroline-Chapel Hill, School of Medicine, Chapel Hill, NC, Department of Radiation Oncology, The University of North Carolina, Chapel Hill, NC

Research Funding

No funding sources reported

Background: CVD is a major cause of mortality in CaP survivors. Prior claims-based studies have reported underutilization of preventive care in cancer survivors, but most CVD preventive care items are not available in claims data. We directly examined the prevalence of CVD risk factors and receipt of care in patients with these risk factors in two population-based data sources: National Health and Nutrition Examination Survey (NHANES) and National Health Interview Survey (NHIS) – both commonly used to examine patterns of care in the US. Methods: 2,938 (NHANES) and 452 (NHIS) men with CaP diagnosed from 1999 to 2011 were included. Statistical analysis accounted for sampling weight, and was stratifiedby Caucasian (CA) vs. non-CA. Results: CVD risk factors are highly prevalent (Table), and appear more so in non-Caucasian survivors. Further, 32% of survivors reported history of actual CVD (prior stroke, myocardial infarction, angina, or coronary heart disease). Overall, the majority of survivors receive preventive care. 89%of CA and non-CA survivors visited a primary care physician in the past 1 year. Among survivors with hypertension or hyperlipidemia, >80% received blood pressure or cholesterol checks within past 1 year. Rates of tobacco cessation and exercise were lower. Conclusions: CVD and associated risk factors are prevalent in CaP survivors. However, the majority of these survivors visit a primary care physician and receive CVD preventive care.

 
 
Risk factor
prevalence
Intervention in those
with risk factor
Intervention in those
without risk factor
NHANES
NHIS
NHANES
NHIS
NHANES
NHIS
Risk factor CA Non-CA CA Non-CA CA Non-CA CA Non-CA CA Non-CA CA Non-CA
Hypertension (%) 58 70 58 71 100 93 97 97 99 95 97 98
Hyperlipidemia (%) 56 61 49 47 84 92 94 89 71 80 84 82
Diabetes (%) 14 25 16 27 -- -- -- -- 63 69 50 53
Tobacco use (%) 8 29 13 25 -- -- 40 49 -- -- -- --
Obesity (%) 26 26 25 38 52 24 45 46 62 43 54 41

Intervention definition Hypertension: Blood pressure check within last year Hyperlipidemia: Cholesterol check within last year Diabetes: Fasting glucose within last 3 years Tobacco use: Intentional smoking cessation in last year Obesity: Moderate exercise at least 1 day in past month

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 185)

DOI

10.1200/jco.2013.31.6_suppl.185

Abstract #

185

Poster Bd #

B9

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Genitourinary Cancers Symposium

Endocrine and metabolic diseases among survivors of prostate cancer in a population-based cohort.

First Author: Siqi Hu

Abstract

2022 ASCO Quality Care Symposium

Racial/ethnic disparities in patient care experiences among prostate cancer survivors: A SEER-CAHPS study.

First Author: Ambrish Pandit

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso